RxDoctor Payments Data

Mark Mahan, DO

Surgery · Danville, PANPI 1841730496

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (37.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 68.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $1,611 and has fallen 90.7% since, to $150 in 2025.

$4,896in general payments, 2019–2025

Across 32 payments — averaging $152.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Medical Device Business Services, Inc.$498
  • Johnson & Johnson$181
  • Boston Scientific$150
  • W. L. Gore & Associates, Inc.$150
  • Haemonetics Corporation$121
  • plus $463 from 5 others

What the payments were for

  • Speaking & faculty fees$1202%
  • Travel & lodging$1,62033%
  • Food & beverage$1,83537%
  • Education$1,30527%
  • Gifts$160%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,896 in reported general payments places this provider in the 75th percentile of 1,424 surgery providers in Pennsylvania.

See all surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$57,210
Medicare patients
113
Services billed
223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate26$1,496
Misoprostol12$1,206
Omeprazole30$312
Ondansetron Hcl11$84

Paid to pharmacies, not to this prescriber.

Other surgery in Danville

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →